Cite
Leehey MA, Liu Y, Hart F, et al. Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis Cannabinoid Res. 2020;5(4):326-336doi: 10.1089/can.2019.0068.
Leehey, M. A., Liu, Y., Hart, F., Epstein, C., Cook, M., Sillau, S., Klawitter, J., Newman, H., Sempio, C., Forman, L., Seeberger, L., Klepitskaya, O., Baud, Z., & Bainbridge, J. (2020). Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis and cannabinoid research, 5(4), 326-336. https://doi.org/10.1089/can.2019.0068
Leehey, Maureen A, et al. "Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study." Cannabis and cannabinoid research vol. 5,4 (2020): 326-336. doi: https://doi.org/10.1089/can.2019.0068
Leehey MA, Liu Y, Hart F, Epstein C, Cook M, Sillau S, Klawitter J, Newman H, Sempio C, Forman L, Seeberger L, Klepitskaya O, Baud Z, Bainbridge J. Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis Cannabinoid Res. 2020 Dec 15;5(4):326-336. doi: 10.1089/can.2019.0068. eCollection 2020. PMID: 33381646; PMCID: PMC7759259.
Copy
Download .nbib